Editverse · Clinical Decision Tools
Free Centor/McIsaac Score Calculator (2026)
The Centor/McIsaac score estimates the probability that a patient’s sore throat is caused by group A Streptococcus (GAS) rather than a virus, using four bedside findings plus an age adjustment. It combines tonsillar exudate or swelling, tender anterior cervical lymphadenopathy, fever, and absence of cough with an age-band point — added for children, subtracted for older adults — into a single score from −1 to 5, which maps to a published probability of streptococcal pharyngitis. It’s built for primary care clinicians, urgent care and emergency physicians, and pediatricians deciding whether a patient with a sore throat needs rapid strep testing, a throat culture, or empiric treatment. One scope note up front: it is validated for patients age 3 and older — it was not derived or validated in infants and toddlers under 3, in whom streptococcal pharyngitis is uncommon and the physical exam is harder to interpret reliably.
Clinical decision-support aid, not a substitute for clinical judgment. These tools implement published scoring criteria for education and workflow support. They are not a medical device and have not been reviewed by the FDA or any regulatory body. Every result should be interpreted by a qualified clinician in the context of the full clinical picture, not used as a standalone diagnostic or treatment decision.
Strep pharyngitis probability
Centor / McIsaac
Select the age band, then check whichever clinical findings are present. The score runs from −1 to 5.
Centor RM, et al. Med Decis Making. 1981;1(3):239–246 (original) · McIsaac WJ, et al. CMAJ. 1998;158(1):75–83 (age modification) · McIsaac WJ, et al. JAMA. 2004;291(13):1587–1595 (large validation).
Worked example
Consider an 8-year-old with a sore throat. The age band (3–14 years) contributes +1 point. On exam, the child has tonsillar exudate (+1), tender anterior cervical lymphadenopathy (+1), a measured fever of 38.6°C (+1), and no cough (+1). Summing the five components gives a Centor/McIsaac score of 5 — the same default the calculator above loads with.
A score of 5 falls in the ≥4 band, corresponding to a 51–53% probability of group A streptococcal pharyngitis, high enough that most protocols recommend confirmatory rapid testing before treating rather than treating empirically.
Methods, assumptions & limitations
Methods sentence. Streptococcal pharyngitis probability was estimated using the Centor score as modified by McIsaac, an additive score (range −1 to 5) derived from tonsillar exudate, tender anterior cervical lymphadenopathy, fever >38°C, absence of cough, and an age-band adjustment (+1 for ages 3–14, 0 for 15–44, −1 for ≥45), mapped to the group A streptococcus probability bands validated by McIsaac and colleagues (Centor et al., 1981; McIsaac et al., 1998; McIsaac et al., 2004).
When not to use this calculator. This score is validated for patients age 3 and older; it was not derived or tested in infants or toddlers under 3, which is why this calculator deliberately does not offer an under-3 age band. It is a clinical probability tool meant to guide the decision to test, not a substitute for an actual positive rapid antigen test or throat culture before starting antibiotics — a high score raises the pretest probability of strep, it does not diagnose it.
On the clinical-use bands. As a general pattern reflected in the literature: scores of 0–1 generally do not warrant testing or antibiotics; a score of 2 makes rapid antigen testing a reasonable option; a score of 3 makes rapid testing the more clearly recommended step; and scores of 4 or higher prompt rapid testing or, in some protocols, empiric treatment — though many guidelines, including IDSA’s, still favor confirmatory testing over empiric antibiotics in adults even at the highest band, specifically to avoid overtreatment.
Common questions
What is the difference between the Centor score and the McIsaac score?
The original Centor score, described in 1981, used four criteria — tonsillar exudate, tender anterior cervical adenopathy, fever, and absence of cough — in adults presenting to an emergency department. McIsaac and colleagues later added an age adjustment (+1 for ages 3–14, no change for 15–44, −1 for 45 and older) and validated the resulting score in a broader primary-care population that included children as young as 3, which is why the combined tool is usually called the Centor/McIsaac score today. In practice, “Centor score” and “McIsaac score” are now used almost interchangeably to refer to the age-adjusted version implemented here.
Does a high Centor/McIsaac score mean a patient needs antibiotics right away?
Not directly — the score estimates probability, not certainty, and even at the top band (score ≥4, 51–53% probability) roughly half of patients will not actually have group A Streptococcus. Most guidelines, including IDSA’s, recommend confirmatory rapid antigen testing or throat culture before starting antibiotics even at a high score, reserving empiric treatment for settings where testing genuinely is not available. The score’s real job is deciding who to test, not who to treat.
Can the Centor/McIsaac score be used in young children?
Only down to age 3. The McIsaac validation studies included children starting at age 3, and the age-band adjustment in this calculator reflects that lower bound — there is deliberately no under-3 option in the age-band selector above. In children younger than 3, streptococcal pharyngitis is uncommon and the exam findings the score relies on are harder to elicit and interpret reliably, so clinical judgment, and where relevant pediatric-specific guidance, should lead instead.
Primary references
- Centor RM, Witherspoon JM, Dalton HP, Brody CE, Link K. The diagnosis of strep throat in adults in the emergency room. Med Decis Making. 1981;1(3):239–246.
- McIsaac WJ, White D, Tannenbaum D, Low DE. A clinical score to reduce unnecessary antibiotic use in patients with sore throat. CMAJ. 1998;158(1):75–83.
- McIsaac WJ, Kellner JD, Aufricht P, Vanjaka A, Low DE. Empirical validation of guidelines for the management of pharyngitis in children and adults. JAMA. 2004;291(13):1587–1595.
Related research support
Turning an interesting pharyngitis case into a publication?
An atypical presentation, a diagnostic pitfall, or a case where the Centor score and the actual culture result disagreed can make a solid primary-care case report or short paper. Editverse’s Essential Editing Package is a low-friction, fixed-price copyediting, proofreading, and journal-formatting service built for exactly that kind of manuscript.